Technologies for detecting falsified and substandard drugs in low and middle-income countries.
Falsified and substandard drugs are a global health problem, particularly in low- and middle-income countries (LMIC) that have weak pharmacovigilance and drug regulatory systems. Poor quality medicines have important health consequences, including the potential for treatment failure, development of...
Main Authors: | Stephanie Kovacs, Stephen E Hawes, Stephen N Maley, Emily Mosites, Ling Wong, Andy Stergachis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3966738?pdf=render |
Similar Items
-
Trade in substandard and falsified medicines
by: Hagen, N, et al.
Published: (2022) -
Substandard and falsified antimicrobials in selected east African countries: A systematic review
by: Addisu Afrassa Tegegne, et al.
Published: (2024-01-01) -
Substandard and falsified antimicrobials in selected east African countries: A systematic review.
by: Addisu Afrassa Tegegne, et al.
Published: (2024-01-01) -
How to achieve international action on falsified and substandard medicines.
by: Attaran, A, et al.
Published: (2012) -
Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
by: Zabala, GA, et al.
Published: (2022)